Skip to main content

Utilizing Technology and Social Media in Oncology Research With Dr. Lisa Carter-Harris and Dr. Kelly Brassil

At the recent 47th Annual Oncology Nursing Society (ONS) Congress in Anaheim, California, Dr. Lisa Carter-Harris of Memorial Sloan Kettering Cancer Center and Dr. Kelly Brassil of MD Anderson Cancer Center each gave a presentation about ethical considerations in oncology research in light of the latest technological platforms and interventions. Afterwards, they spoke with Oncology Data Advisor to further explain the roles of technology and social media in oncology research and the implications o...

Continue reading

Can Digital Life Coaching During Transplant for Multiple Myeloma Improve Quality of Life? Insights From Rahul Banerjee, MD, and Kelly Brassil, PhD, RN, FAAN

Rahul Banerjee, MD, and Kelly Brassil, PhD, RN, FAAN.

Patients undergoing autologous stem cell transplant (ASCT) for multiple myeloma face significant challenges in quality of life, including anxiety, acute symptom burden, and decreased physical function. At the recent 63rd American Society of Hematology (ASH) Annual Meeting & Exposition in Atlanta, Georgia, Dr. Rahul Banerjee and Dr. Kelly Brassil presented their research regarding digital life coaching for this patient population. In this interview with Oncology Data Advisor, Dr. Banerjee and Dr. Brassil discuss their results from a prior pilot study on this topic, the design of an ongoing phase 2 trial to continue the research, and its implications for improving the quality of life for patients undergoing ASCT for multiple myeloma.  

Continue reading

The Promising Effects of Patient-Reported Symptom Data on Survival and Well-Being: A Conversation With Dr. Kelly Brassil

Welcome to Oncology Data Advisor, where we explore the latest advances in cancer research and treatment. I am Selma Khenissi from i3 Health. In this podcast, Dr. Kelly Brassil, PhD, RN, from The University of Texas MD Anderson Cancer Center, will be discussing patient-reported symptom data and how it affects patient survival and quality of life. Selma Khenissi, MPS: Can you comment on how tools such as Project Patient Voice positively impact the outcomes of patients with classical Hodgkin lympho...

Continue reading